Dark
Streaming/Mobile
OldĀ Site
Home
Products
Help
Contact Us
Your Account
System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
10:53:43 EST Fri 08 Nov 2024
Quotes
Streaming/Mobile
Quick Quotes (x20)
Symbol Search
Company Search
Market Depth
US Options
Montreal Options
Foreign Exchange
Download Close Prices
Short History
Quotes Help
Charts
12 Month Chart
Advanced Chart
Live Intraday Chart
Live Historical Chart
Live Java Intraday Chart
Live Java Historical Chart
Charts Help
News
News Search
SEDAR Search
SEDAR Alerts
News Help
Indexes
Major Indexes
US incl Dow Jones
NASDAQ
S&P CME
PBOT - Phil Ex
TSX - Toronto
TSX-V - TSX Venture
Indexes Help
Portfolio
View Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Value Portfolio
All Portfolios
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Edit Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Chart Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Live Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
View Portfolio News
Daily Summary
Portfolio Help
Analytics
Exchange Statistics
Most Active
Live Most Active
Block Trades
Broker Trades
Halted Stocks
Dividends
Participants
Companies
Trade Workstation
Company Picker
Short Positions
Broker Codes
Analytics Help
Mutual Funds
Mutual Fund Search
Targeted Holder Search
SEDAR Fund Search
Mutual Fund Help
Enter Symbol
or Name
USA
CA
Quote
Chart
News
Closes
Depth
Forgot password?
Trouble logging in?
Login ID:
Password:
Save
Q:EOLS
- EVOLUS INC -
https://investors.evolus.com/
10:53:43 EST
Sym-X
Bid - Ask
Last
Chg
%Ch
Vol
$Vol
#Tr
Open-Hi-Lo
Year Hi-Lo
Last Tr
News
Delay
EOLS
- Q
0.1
13.77
·
13.83
0.1
13.83
-0.46
-3.2
241.2
3,208
1,993
14.28
14.35
13.72
17.82 7.74
10:32:44
Nov 06
15 min
RT 2¢
Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
Nasdaq Indicators -- Market:
Nasdaq
-- Bid Tick:
Up
-- UPC Restricted:
No
Fundamentals
·
Holders
·
Trade Workstation
·
Market Depth
·
3 Month Closes
·
Technical Charts
1 yr
|
2 yr
|
3 yr
|
5 yr
|
10 yr
|
15 yr
|
20 yr
·
Live Charts
1 yr
|
1 day
·
1yr Bulletins
·
Historical
·
Options
·
Portfolio
Recent Trades - Last 10 of 1993
More trades...
Time ET
Ex
Price
Change
Volume
10:32:44
Q
13.7892
-0.5008
100
10:32:34
Q
13.7603
-0.5297
14
10:32:32
Q
13.7981
-0.4919
18
10:32:24
Q
13.83
-0.46
3
10:32:24
Q
13.83
-0.46
500
10:32:24
Q
13.83
-0.46
25
10:32:23
Q
13.80
-0.49
23
10:32:09
Q
13.8028
-0.4872
1
10:32:01
Q
13.80
-0.49
47
10:31:58
Q
13.80
-0.49
100
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
Recent Bulletins
News Releases
In The News
Other
Date ET
Symbol
Type
Headline
2024-11-06 16:05
U:EOLS
News Release
200
Evolus Reports Third Quarter 2024 Results
2024-11-01 08:00
U:EOLS
News Release
200
Evolus to Participate in Stifel 2024 Healthcare Conference
2024-10-31 14:02
U:EOLS
News Release
200
Evolus Announces EU Approval of Estyme(TM) Injectable Hyaluronic Acid Gels Under New Medical Device Regulation
2024-10-29 08:00
U:EOLS
News Release
200
Evolus Rewards(TM) Patient Loyalty Program Surpasses 1 Million Enrolled Consumers
2024-10-23 08:00
U:EOLS
News Release
200
Evolus to Report Third Quarter Financial Results on November 6, 2024
2024-10-11 22:53
U:EOLS
News Release
200
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2024-09-27 21:00
U:EOLS
News Release
200
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2024-09-06 08:00
U:EOLS
News Release
200
Evolus to Ring the Nasdaq Stock Market Closing Bell on Friday, September 13, 2024
2024-08-09 16:30
U:EOLS
News Release
200
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2024-07-31 16:05
U:EOLS
News Release
200
Evolus Reports Second Quarter 2024 Results and Raises Full Year Revenue Guidance
2024-07-31 08:00
U:EOLS
News Release
200
Evolus to Hold Investor Day on September 12, 2024
2024-07-30 08:00
U:EOLS
News Release
200
Evolus Expands Global Footprint with Introduction of Nuceiva(TM) (botulinum toxin type A) in Australia
2024-07-25 08:00
U:EOLS
News Release
200
Evolus to Participate in the Canaccord Genuity 44th Annual Growth Conference
2024-07-17 08:00
U:EOLS
News Release
200
Evolus to Report Second Quarter Financial Results on July 31, 2024
2024-07-01 08:00
U:EOLS
News Release
200
Evolus Announces Appointment of Albert G. White III to Board of Directors
2024-06-24 08:00
U:EOLS
News Release
200
Evolus Announces Submission of Premarket Approval Application to the U.S. Food and Drug Administration for First Two Evolysse(TM) Dermal Filler Products
2024-06-12 08:00
U:EOLS
News Release
200
Evolus Broadens International Presence with Launch of Nuceiva(TM) (botulinum toxin type A) in Spain
2024-06-07 17:00
U:EOLS
News Release
200
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2024-05-20 08:30
U:EOLS
News Release
200
Evolus Announces Positive Data from Pivotal Trial for First Two Evolysse(TM) Dermal Filler Products at 2024 SCALE Meeting
2024-05-10 18:55
U:EOLS
News Release
200
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)